Tuesday, April 28, 2020

LabCorp's at-home coronavirus testing kit authorized by FDA

LabCorp's at-home coronavirus testing kit authorized by FDA

FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products Targeted to Youth from the Market

Agency Continues to Target the Sale of Unauthorized, Flavored E-cigarette Products That Appeal to Youth
Today, the U.S. Food and Drug Administration issued ten warning letters to retailers and manufacturers who sell, manufacture and/or import unauthorized electronic nicotine delivery system (ENDS) products targeted to youth or likely to promote use by youth. The warning letters were sent to establishments marketing unauthorized products, such as a backpack and sweatshirt designed with stealth pockets to hold and conceal an e-cigarette, ENDS products that resemble smartwatches, or devices appearing as children’s toys such as a portable video game system or fidget spinner. Warning letters were also issued to...

FDA Provides Updates on Adverse Event Reports and Postmarket Activities Associated with Essure

Today, the U.S. Food and Drug Administration issued a letter to Bayer outlining conditions for submitting additional postmarket information to the agency about Essure—a permanent birth control device Bayer sold in the U.S. until 2018. The letter applies to reportable adverse events Bayer is or becomes aware of from social media information received in relation to ongoing litigation regarding Essure.

Because of the anticipated volume and nature of this information, the FDA granted Bayer’s request for a variance from some medical device reporting requirements but imposed conditions for reporting to ensure protection of the public health. Under the conditions, Bayer is required to ...

Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal

Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal

India pharma manufacturing hub back up and running after COVID-19 lockdown: report

India pharma manufacturing hub back up and running after COVID-19 lockdown: report